On July 21, 2015, an Illinois couple filed a new Zofran birth defects lawsuit on behalf of their young son. They claim that the mother’s intake of Zofran during pregnancy caused the baby to suffer a congenital heart defect. The couple blames manufacturer GlaxoSmithKline (GSK)…
The Food and Drug Administration (FDA) approved Invokana (canagliflozin) for the treatment of type 2 diabetes in March 2013. After just a year on the market, the new drug was linked with 457 reports of adverse events, including serious side effects like kidney failure or…
Two new studies have raised additional concerns about Xarelto (rivaroxaban) excessive bleeding events. Both link the anticoagulant drug to serious risks of side effects that could result in hospitalization and even death. Xarelto was approved by the FDA in 2011 to reduce the risk of…
A New Jersey couple recently filed a new Zofran lawsuit, claiming that manufacturer GlaxoSmithKline (GSK) is liable for their child’s birth defects. This is one of many similar lawsuits pending in federal and state courts across the country. GSK recently filed a motion requesting consolidation…
A number of women have blamed the anti-nausea drug Zofran (ondansetron) for causing their children’s birth defects. Had they known that the drug could increase risk of such defects, many say, they never would have taken it. Unfortunately, Zofran manufacturers GlaxoSmithKline (GSK) conducted a large…
In June 2015, professors of medicine Steven Woloshin and Lisa M. Schwartz from the Dartmouth Institute for Health Policy and Clinical Practice published an editorial on testosterone drug risks in the Washington Post. In it, the authors criticized testosterone drug therapy manufacturers for creating
On May 15, 2015, the FDA issued a drug safety communication notifying healthcare providers and diabetes patients that type 2 diabetes drugs like Invokana could increase the risk of diabetic ketoacidosis. (DKA). This is a very serious condition in which the blood becomes too acidic.…
The newer-generation anticoagulant Xarelto (rivaroxaban) has ended up in the news lately because of its connection to serious side effects like gastrointestinal bleeding, brain hemorrhaging, blood clots, and stroke. A recent study, however, has now raised additional concerns that Xarelto may be dang
Though Zofran lawsuits have not yet been consolidated into one court, litigation continues to grow. Just in the last few weeks, three more cases were filed in different federal courts, each claiming that Zofran (ondansetron) manufacturers GlaxoSmithKline (GSK) failed to provide adequate warnings abo
On June 22, 2015, Health Canada announced that it was investigating the safety of Invokana (canagliflozin) and other similar medications because of concerns these type 2 diabetes drugs may increase risk of ketoacidosis. Ketoacidosis is a condition in which the pH balance in the blood…
It’s been just over a year since the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed testosterone lawsuits into one court in the Northern District of Illinois. Today, over 1,800 cases are pending, with plaintiffs bringing claims against the manufacturers of An
The type 2 diabetes drug Invokana (canagliflozin) has been linked with “ketoacidosis,” a serious condition that can lead to hospitalization, coma, and even death. The FDA recently released a drug safety communication warning healthcare providers to be on the watch for symptoms like nausea and…